Tharimmune
Biotechnology company(THAR)Projets similaires
*Si ce n’est pas cliquable, cela signifie qu’aucune information détaillée n’est disponible.
The Ether Machine
Ethereum Yield and Infrastructure Company(Nasdaq:ETHM)
Fold
Bitcoin Financial Services Company(NASDAQ: FLD) 
Quantum Solutions
AI technology listed company(TSE: 2338.T)
Tron Inc
Design and development company（Nasdaq：SRM）
DV8 Public Company Limited
Advertising Media(SET:DV8)
H100 Group
Health technology and investment consulting（NGM：H100）
BTC Digital
Cryptocurrency Technology Corporation（Nasdaq：BTCT）
Rumble
Decentralized Video Streaming (Nasdaq: RUM)A propos de Tharimmune
Communauté
Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
Investisseurs
Liberty City Ventures
DRW Venture Capital
Kraken
PolychainA
ARK InvestDétails du financement
| Cycle de funding | Montant | Estimation | Date | Investisseurs |
|---|---|---|---|---|
IPO | €468.84M | -- | 2025-11-03 |  Liberty City Ventures* DRW Venture Capital*+ 3 |